Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01924559 · ClinicalTrials.gov registry record · NA
Comparison of Airway Intubation Devices When Using a Biohazard Suit
A NA study, sponsored by Lehigh Valley Hospital.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT01924559: Completed NA study, sponsored by Lehigh Valley Hospital.
NCT01924559 is a NA study that has completed, run by Lehigh Valley Hospital. The registered enrollment target is 37 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01924559, a NA study, has completed, sponsored by Lehigh Valley Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
We will investigate the impact biohazard gear has on time to successful intubation and, in particular, determine how the Supraglottic Airway Laryngopharyngeal Tube (Ecolab, Columbus, Missouri) device compares to traditional direct laryngoscopy and fiber-optic (video) intubation techniques.
Primary Outcome
Time from initiation of intubation attempt to successful 2 breaths demonstrating lung expansion, estimated less than 1 minute
Interventions
- DEVICE Direct Laryngoscopy
- DEVICE Glidescope
- OTHER standard clothing
- OTHER Biohazard gear
- DEVICE Supraglottic Airway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2013-08 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT01924559 record still lists
NCT01924559 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Direct Laryngoscopy is the first listed.
NCT01924559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01924559 about?
NCT01924559 is a clinical study titled "Comparison of Airway Intubation Devices When Using a Biohazard Suit". We will investigate the impact biohazard gear has on time to successful intubation and, in particular, determine how the Supraglottic Airway Laryngopharyngeal Tube (Ecolab, Columbus, Missouri) device compares to traditional direct laryngoscopy and fiber-optic (video) intubation techniques.
What is the current status of trial NCT01924559?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2013-08. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01924559?
The interventions under investigation include: Direct Laryngoscopy (DEVICE), Glidescope (DEVICE), standard clothing (OTHER), Biohazard gear (OTHER), Supraglottic Airway (DEVICE).
Who is sponsoring clinical trial NCT01924559?
This trial is sponsored by Lehigh Valley Hospital, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01924559's enrollment target sits among peer trials
37 1540th of 2000 higher than 460 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia